AEI Healthcare Portfolio III DST

AEI Healthcare Portfolio III DST

Five debt-free properties occupied by multi-billion dollar corporate tenants

aei-hcp-iii-dst-2
aei-hcp-iii-dst-5
aei-hcp-iii-dst-6
aei-hcp-iii-dst-7
aei-hcp-iii-dst-8
Total offering: $26,078,000

Debt: None (Debt-free)

  • Initial annual distribution rate: 5.01%
  • Distribution frequency: Monthly
  • Average remaining lease term: 14.50 years
  • Minimum investment: $100,000 for a 1031 exchange
SCHEDULE A CONSULTATION

AEI Healthcare Portfolio III DST consists of five single-tenant, net leased properties stuctured as a Delaware Statutory Trust (DST) suitable for 1031 exchange or direct investment.

Five debt-free properties occupied by multi-billion dollar corporate tenants

This offering is designed for accredited investors seeking stable, long-term income and tax deferral through a high-quality, fractional real estate investment.

Investment Overview

AEI Healthcare Portfolio III DST consists of five single-tenant, net leased properties stuctured as a Delaware Statutory Trust (DST) suitable for 1031 exchange or direct investment. This offering is designed for accredited investors seeking stable, long-term income and tax deferral through a high-quality, fractional real estate investment.

  • Total offering: $26,078,000
  • Debt: None (Debt-free)
  • Initial annual distribution rate: 5.01%
  • Distribution frequency: Monthly
  • Average remaining lease term: 14.50 years*
  • Anticipated exit strategy: Liquidate approximately 10 years after completion of the offering period
  • Minimum investment: $50,000 for a cash investment

Portfolio Assets

  • Markets: Three distinct markets throughout the United States
  • Sectors: Each tenant operates in a specific medical sector 
  • Tenants: Each property is net leased to an industry-leading corporate tenant 
  • Leases: All leases are long-term, full faith and credit net leases 
  • Escalators: All leases include contractual rental escalators increasing income over time
  • National Diversif ication: Prior to purchase, each property and location was subjected to extensive due diligence to create a diversified portfolio of commercial properties leased to well-known companies in superior locations across the United States. 

BioLife Plasma Services

About the Tenant:

BioLife Plasma Services is an industry leader for the collection of high-quality plasma that is processed into life-saving therapies. The company operates numerous state-of-the-art plasma collection facilities throughout the United States and Austria.

Baxalta Inc., the parent company of BioLife Plasma Services, is the lease guarantor. Baxalta is a leading biopharmaceutical company that advances innovative therapies in hematology, immunology, oncology for the treatment of hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, and other chronic diseases. Baxalta’s global net sales totaled $6.15 Billion in 2015, an increase of 3.3% over 2014 and has a total equity of $3.9 Billion. In June of 2016, Baxalta completed a $32 Billion merger with Shire Pharmaceuticals, creating what it called the global market leader in the treatment of rare diseases and other specialized disorders.

Fresenius Kidney Care

About the Tenant: Fresenius Medical Care Ag & Co KGaA (NYSE: FMS)

Fresenius Medical Care Ag & Co KGaA (FMS), is the world’s largest integrated provider of products and services for individuals undergoing dialysis treatment due to chronic kidney failure, a condition that affects more than 3.9 million individuals worldwide. With more than 3,700 kidney dialysis clinics in approximately 150 countries, FMS provides treatment to more than 320,000 patients. FMS is also the world’s preeminent provider of dialysis products. In 2016, 50% of dialysis machines sold worldwide were produced by FMS.

Fresenius Medical Care Holdings, Inc. (FMCH), is the lease guarantor and is the North American subsidiary of FMS. FMCH employs approximately 67,000 people. In 2017, FMCH reported revenues of $15.01 Billion.

DaVita, Inc.

About the Tenant: (NYSE: DVA)

DaVita, Inc. (DVA) was founded in 1994 and is a leading provider of dialysis services in the United States. The company specializes in the treatment of patients with chronic kidney failure and end-stage renal disease. DVA also operates DaVita Rx, a pharmacy that provides oral medications to patients with end-stage renal disease. As of June 30, 2017, DaVita Kidney Care operated or provided administrative services at 2,445 outpatient dialysis centers located in the United States, serving nearly 200,000 patients. The company also operated 217 outpatient dialysis centers located in 11 countries outside of the United States. DVA is headquartered in Denver, Colorado and employs more than 50,000 team members. As of December 2016, DVA had total revenues of $14.7 Billion, net income of $880 Million, and total equity of $4.6 Billion.

Location:
400 North Lindbergh Boulevard, Creve Coeur, MO

Creve Coeur, MO is located 14 miles west of St. Louis, which is the 20th largest metropolitan area in the nation. St. Louis has long been a national leader in both healthcare and medical/life sciences research. Additionally, there are nine FORTUNE 500 companies headquartered in St. Louis, including: Emerson, Monsanto, and Express Scripts Holding.

The property is located on highway 67 with access to both interstate 270 and 64: major thoroughfares in and around St. Louis. The surrounding area includes multiple retailers, restaurants, banks and medical providers, including Mercy Children’s Hospital of St. Louis and Mosanto’s corporate headquarters.

ABOUT AEI

Founded in 1970, AEI is one of America’s oldest sponsors of net lease real estate investment programs and a leader in the TIC- 1031 exchange industry. AEI is a national source of high quality, commercial real estate for property owners engaged in 1031 tax-deferred property exchanges. AEI has specialized in developing, evaluating and purchasing these types of properties for more than 35 years and offers a portfolio of name-brand, net leased commercial retail properties.

Why come to AEI for your TIC or 1031 properties?

Exceptional service. If this is your first 1031 property exchange or TIC purchase, we make every effort to ensure that you fully understand the transaction. Our experienced professionals are available to assist you at each step.

Stability and quality. AEI offers quality, single tenant properties – freestanding real estate occupied by creditworthy corporate tenants under long-term net leases.

Acquisition expertise. AEI has performed institutional-grade due diligence on every property we own. Acquiring property from AEI can reduce this time-consuming, labor-intensive aspect of your property selection process and provide a higher level of expertise than you may be able to provide yourself.

Post-purchase services. After your property purchase is complete, AEI can provide the following services:

  • Accounting and distribution of rental income
  • Year-end 1099 forms for tax reporting
  • Assisting with any management concerns you may have about your property
  • Monitoring lease compliance, tax and insurance payments, and property maintenance by the tenant
DST investment professionals like-kind property 1031 tax deferred exchange net-net-net back up plan exchange 1031 45 days exchange period Qualified Intermediary 1031 Exchange advisor income tax benefits 1031 exchange 1031 exchange process 1031 Exchange for Dummies Defer Capital Gains Tax section 1031 1031 property 1031 Exchange Rules 1031 exchange backup plan 1031 tax deferred exchanges 1031 exchange replacement property TIC property construction 1031 exchange triple net lease properties 1031 qualified intermediary Real Estate Investor 1031 exchange property DST 1031 Exchanges DST TIC investment professionals. 1033 exchange TIC Investors DST property DST 1031 Properties TIC Properties TIC 1031 dst Exchange NNN 1031 Exchange NNN Lease 1031 exchange properties nnn tenant listing TIC investment 1031 Exchange DST investment NNN Lease Investment NNN properties 1031 Dst properties 1031 exchange

Disclaimer

1031Sponsors.com is a web portal owned by Investment.Net, LLC. The company is functioning in the 1031 exchange market for more than 15 years. Neither Investment.Net nor 1031Property intend to act as a broker or sell any goods or services. 1031Sponsors does not offer legal or tax advice. Tax topics discussed are for educational purposes only and should not be considered professional tax advice. It's recommended that you discuss your situation with your tax or legal advisor. Distributing an investment in different assets or choosing alternative investments involves higher risks than traditional investments and shouldn't be taken for granted. All alternative investment strategies are sold along with a prospectus that discloses all risks, fees, and expenses. These investments are not tax-efficient, and an investor should consult with his/her tax advisor before investing. The investor should be prepared to bear loss knowing that financial risks are attached to such investments.

1031Sponsors help investors residing in the United States complete their 1031 exchanges by providing them well-researched and authentic information related to 1031 exchanges. Services listed on the website 1031Sponsors.com can be modified to make them relevant to the present investment situation in the United States. For additional information, please contact 888-876-6005.

Get Access
Call Now